Asia Medical & Agricultural Laboratory & Research Center PCL
Asia Medical and Agricultural Laboratory and Research Center Public Company Limited provides scientific services for the agriculture, food, pharmaceutical, and environment industries in Thailand. The company offers one stop and customized services, and quality, contaminants, additive services for meat and meat products, fats and oils, pet food, feedstuffs and feed raw materials, aquaculture aquat… Read more
Asia Medical & Agricultural Laboratory & Research Center PCL (AMARC) - Net Assets
Latest net assets as of September 2025: ฿613.51 Million THB
Based on the latest financial reports, Asia Medical & Agricultural Laboratory & Research Center PCL (AMARC) has net assets worth ฿613.51 Million THB as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (฿720.69 Million) and total liabilities (฿107.18 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ฿613.51 Million |
| % of Total Assets | 85.13% |
| Annual Growth Rate | 29.29% |
| 5-Year Change | 169.04% |
| 10-Year Change | N/A |
| Growth Volatility | 57.14 |
Asia Medical & Agricultural Laboratory & Research Center PCL - Net Assets Trend (2018–2024)
This chart illustrates how Asia Medical & Agricultural Laboratory & Research Center PCL's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Asia Medical & Agricultural Laboratory & Research Center PCL (2018–2024)
The table below shows the annual net assets of Asia Medical & Agricultural Laboratory & Research Center PCL from 2018 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | ฿521.05 Million | +1.31% |
| 2023-12-31 | ฿514.33 Million | -6.13% |
| 2022-12-31 | ฿547.90 Million | +158.63% |
| 2021-12-31 | ฿211.84 Million | +9.38% |
| 2020-12-31 | ฿193.67 Million | +12.43% |
| 2019-12-31 | ฿172.26 Million | +54.49% |
| 2018-12-31 | ฿111.50 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Asia Medical & Agricultural Laboratory & Research Center PCL's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 211.2% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | ฿24.95 Million | 4.79% |
| Other Components | ฿496.10 Million | 95.21% |
| Total Equity | ฿521.05 Million | 100.00% |
Asia Medical & Agricultural Laboratory & Research Center PCL Competitors by Market Cap
The table below lists competitors of Asia Medical & Agricultural Laboratory & Research Center PCL ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
META WOLF AG INH O.N.
F:WOLF
|
$10.74 Million |
|
Jullundur Motor Agency (Delhi) Limited
NSE:JMA
|
$10.74 Million |
|
Harbor Diversified
PINK:HRBR
|
$10.75 Million |
|
Arcure S.A.
F:340
|
$10.75 Million |
|
SERGEFERRARI GROUP EO-40
F:SFK
|
$10.74 Million |
|
Alchemy Investments Acquisition Corp 1 Units
NASDAQ:ALCYU
|
$10.73 Million |
|
Greenvale Mining Limited
PINK:GVLMF
|
$10.73 Million |
|
Nextedia
PA:ALNXT
|
$10.73 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Asia Medical & Agricultural Laboratory & Research Center PCL's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 514,330,390 to 521,049,366, a change of 6,718,976 (1.3%).
- Net income of 39,898,928 contributed positively to equity growth.
- Dividend payments of 33,157,430 reduced retained earnings.
- Other comprehensive income decreased equity by 8,284,749.
- Other factors increased equity by 8,262,227.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ฿39.90 Million | +7.66% |
| Dividends Paid | ฿33.16 Million | -6.36% |
| Other Comprehensive Income | ฿-8.28 Million | -1.59% |
| Other Changes | ฿8.26 Million | +1.59% |
| Total Change | ฿- | 1.31% |
Book Value vs Market Value Analysis
This analysis compares Asia Medical & Agricultural Laboratory & Research Center PCL's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.81x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 3.75x to 2.81x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2018-12-31 | ฿0.93 | ฿3.48 | x |
| 2019-12-31 | ฿1.44 | ฿3.48 | x |
| 2020-12-31 | ฿1.61 | ฿3.48 | x |
| 2021-12-31 | ฿1.77 | ฿3.48 | x |
| 2022-12-31 | ฿1.68 | ฿3.48 | x |
| 2023-12-31 | ฿1.22 | ฿3.48 | x |
| 2024-12-31 | ฿1.24 | ฿3.48 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Asia Medical & Agricultural Laboratory & Research Center PCL utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 7.66%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 11.56%
- • Asset Turnover: 0.54x
- • Equity Multiplier: 1.23x
- Recent ROE (7.66%) is above the historical average (7.50%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2018 | 3.34% | 2.28% | 0.77x | 1.90x | ฿-7.43 Million |
| 2019 | 10.56% | 9.20% | 0.71x | 1.61x | ฿964.60K |
| 2020 | 14.68% | 12.94% | 0.53x | 2.16x | ฿9.06 Million |
| 2021 | 11.74% | 10.11% | 0.55x | 2.12x | ฿3.68 Million |
| 2022 | 2.65% | 5.51% | 0.38x | 1.28x | ฿-40.27 Million |
| 2023 | 1.88% | 3.33% | 0.45x | 1.26x | ฿-41.79 Million |
| 2024 | 7.66% | 11.56% | 0.54x | 1.23x | ฿-12.21 Million |
Industry Comparison
This section compares Asia Medical & Agricultural Laboratory & Research Center PCL's net assets metrics with peer companies in the Scientific & Technical Instruments industry.
Industry Context
- Industry: Scientific & Technical Instruments
- Average net assets among peers: $645,147,000
- Average return on equity (ROE) among peers: 18.10%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Asia Medical & Agricultural Laboratory & Research Center PCL (AMARC) | ฿613.51 Million | 3.34% | 0.17x | $10.74 Million |
| D.T.C. Enterprise PCL (DTCENT) | $645.15 Million | 18.10% | 0.50x | $8.09 Million |